Study highlights dried blood spot omega-3 testing in dogs

A new short communication in Acta Veterinaria Hungarica puts a practical spin on a familiar nutrition topic: omega-3 fatty acids in dogs. Rather than revisiting whether EPA and DHA matter, the paper focuses on how to measure omega-3 status more easily, pointing to dried blood spot testing as a workable path for estimating the canine Omega-3 Index and discussing the idea through a dermatology lens. (pubmed.ncbi.nlm.nih.gov)

That matters because omega-3 supplementation is already common in small animal practice, particularly for chronic inflammatory conditions. In dogs, EPA and DHA are used in settings ranging from dermatology to osteoarthritis and renal support, but clinicians often have limited ways to confirm whether a patient is reaching a therapeutic fatty acid status over time. Red blood cell fatty acid composition is considered a more stable marker than plasma because it reflects longer-term exposure rather than short-term dietary swings. (pubmed.ncbi.nlm.nih.gov)

The short communication builds on earlier published validation work from 2022 showing that the Omega-3 Index in dogs can be predicted from dried blood spot analysis. In that study, investigators analyzed dried blood spot and red blood cell samples from 33 dogs and found a very strong relationship between dried blood spot EPA+DHA and the red blood cell Omega-3 Index, with an R² above 0.96. The authors concluded that dried blood spot sampling could facilitate omega-3 research in companion animals because collection and handling are simpler than conventional red blood cell testing. (pubmed.ncbi.nlm.nih.gov)

The dermatology angle is where this becomes more clinically interesting. Prior canine studies have linked omega-3 supplementation with improvements in pruritus, coat quality, and seborrheic signs. A randomized, placebo-controlled trial published in 2020 found that an n-3 supplement improved clinical signs and changed fatty acid concentrations in erythrocyte membranes, hair shafts, and the skin surface of dogs with poor quality coats. Earlier work in pruritic skin disease also reported improvement in itching, self-trauma, and coat character with marine oil supplementation. (pubmed.ncbi.nlm.nih.gov)

At the same time, the broader evidence base remains nuanced. A systematic review of EPA/DHA use in companion animals described skin disorders as one of the main non-neoplastic areas where omega-3s appear to have impact, but it did not suggest a one-size-fits-all effect. Guidance and reviews also note an important practical issue: many diets and supplements marketed around omega-3s may not provide enough EPA and DHA for disease management, and some rely heavily on alpha-linolenic acid, which is not biologically equivalent to EPA and DHA. Potential adverse effects, including concerns around high-dose use, oxidative stress, gastrointestinal effects, or perioperative considerations, still need to be weighed. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinarians and nutrition-minded teams, the real value here is less about a new therapy and more about a possible monitoring tool. If dried blood spot testing proves reliable and scalable in practice, it could help clinicians move beyond “we added fish oil” toward a more measurable conversation: did the patient’s omega-3 status actually change, was the dose adequate, and is there a relationship between biomarker change and improvement in skin disease? That could be especially useful when pet parents are using over-the-counter supplements of uneven quality, when multiple diets are in play, or when clinicians want to document response over time. (pubmed.ncbi.nlm.nih.gov)

There are still limits. The underlying validation dataset was small, and the newer short communication appears to be more conceptual than practice-changing on its own. It supports the idea that the Omega-3 Index framework may be transferable to dogs, but it does not yet establish widely accepted canine target ranges for dermatologic disease the way human cardiology has done for people. Inference: the field is moving toward biomarker-guided nutrition, but it is not there yet in a standardized, guideline-backed sense. (pubmed.ncbi.nlm.nih.gov)

What to watch: Expect the most meaningful next developments to be studies that tie dried blood spot-derived omega-3 values to defined clinical endpoints in canine dermatology, along with work on reference intervals, dose-response thresholds, and supplement quality across commercial products. (pubmed.ncbi.nlm.nih.gov)